Even light-intensity activities such as walking can reduce one’s risk for clinical depression. So, what are the most common ...

Discover 7 strategies to combat depression, from spiritual practices to physical wellness, shared through one person's inspiring journey to mental wellbeing.

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

Part of you is concerned — after all, you know depression can be serious — but on the other hand, can’t weight loss be a good ...

Your social circle might be the key to a long, happy life. That’s according to Simon Sinek, a best-selling author and ...

The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

Blue Monday originated from a publicity stunt, but seasonal affective disorder is a real affliction that affects millions of ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to ...

Dr. Joao de Quevedo with UTHealth Houston shares what researchers found during a clinical trial for Spravato, the first FDA-approved nasal spray to treat depression.